XC
TAK icon

XY Capital’s Takeda Pharmaceutical TAK Stock Holding History

XY Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.6M Buy
+1,407,340
New +$24.9M 22.14% 1
2025
Q4 		– Sell
-200,033
Closed -$2.93M – 306
2025
Q3 		$2.93M Buy
+200,033
New +$2.97M 1.54% 16
2025
Q2 		– Sell
-95,830
Closed -$1.42M – 194
2025
Q1 		$1.42M Sell
95,830
-66,872
-41% -$937K 0.4% 62
2024
Q4 		$2.15M Sell
162,702
-1,784
-1% -$24.5K 1.04% 25
2024
Q3 		$2.34M Sell
164,486
-179,563
-52% -$2.55M 0.8% 24
2024
Q2 		$4.45M Buy
344,049
+121,771
+55% +$1.61M 2.81% 7
2024
Q1 		$3.09M Sell
222,278
-542,859
-71% -$7.89M 1.38% 22
2023
Q4 		$10.9M Buy
765,137
+621,440
+432% +$8.82M 6.38% 3
2023
Q3 		$2.22M Buy
143,697
+65,666
+84% +$1.02M 1.28% 20
2023
Q2 		$1.23M Buy
+78,031
New +$1.28M 0.88% 38

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Managed Asset Portfolios
Managed Asset Portfolios Rochester, Michigan $902M AUM 36.95% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

XY Capital's TAK Position: Q3 2026 in Review

XY Capital opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 1,407,340 shares worth $25.6M. The stake represents 22.14% of the portfolio and ranks #1 among its holdings. This is a return to the name: XY Capital previously reported a position in TAK as recently as Q3 2025.

XY Capital first reported a position in TAK in Q2 2023 and has held it in 10 quarters since. 293 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • XY Capital held 1,407,340 shares of Takeda Pharmaceutical worth $25.6M as of Q3 2026.
  • Takeda Pharmaceutical was a new XY Capital position in Q3 2026.
  • Takeda Pharmaceutical made up 22.14% of XY Capital's portfolio in Q3 2026, its #1 holding.
  • XY Capital first reported a position in Takeda Pharmaceutical in Q2 2023 and has held it in 10 quarters since.
  • 293 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on XY Capital's 13F filing for Q3 2026, filed 13 Nov 2026.